NCT03731871

Brief Summary

\- Lung maturity is one of the most important factors in perinatal medicine

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 6, 2018

Completed
6 days until next milestone

Study Start

First participant enrolled

November 12, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2020

Completed
Last Updated

January 27, 2020

Status Verified

January 1, 2020

Enrollment Period

1.7 years

First QC Date

November 3, 2018

Last Update Submit

January 24, 2020

Conditions

Pregnancy Related

Outcome Measures

Primary Outcomes (1)

  • The number of fetuses who will be mature postnatally

    the neonates who willnot need incubators

    within 2 weeks

Interventions

UltrasonographyDIAGNOSTIC_TEST

ultrasound to evaluate parameters of fetal maturity during pregnancy

Eligibility Criteria

Age22 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant ladies
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

pregnant ladies from 28 weeks till term

You may qualify if:

  • pregnant ladies from 28 weeks till term

You may not qualify if:

  • pregnant ladies before 28 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Algazeerah and Kasralainy hospital

Giza, Egypt

NOT YET RECRUITING

Algazeerah and Kasralainy hospital

Giza, Egypt

RECRUITING

MeSH Terms

Interventions

Ultrasonography

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mahmoud Alalfy, PhD

    Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

    STUDY CHAIR

Central Study Contacts

Mahmoud Alalfy, PhD

CONTACT

01002611058mahmoudalalfy@ymail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital

Study Record Dates

First Submitted

November 3, 2018

First Posted

November 6, 2018

Study Start

November 12, 2018

Primary Completion

July 15, 2020

Study Completion

August 20, 2020

Last Updated

January 27, 2020

Record last verified: 2020-01

Locations

EG(2)